L. Demarinis et al., NALOXONE INFLUENCE ON THE GROWTH-HORMONE, PROLACTIN AND THYROTROPIN RESPONSE TO THYROTROPIN-RELEASING-HORMONE IN ACROMEGALIC PATIENTS, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 104(1), 1996, pp. 67-71
In order to gain insight into the neuroendocrine mechanism underlying
the paradoxical GH response to TRH in acromegalic patients, we have in
vestigated the effect of an infusion of Naloxone (Nal, 1.6 mg/hr for t
wo hours), on a TRH test performed both in responder (n = 9) and non-r
esponder (n = 5) acromegalic patients. The response of GH, PRL and TSH
to TRH injection were evaluated. NAL did not exert significant variat
ions in the GH response, even if different patterns of GH response dur
ing NAL were observed in the group of TRH-responder patients. Similarl
y, TRH-induced PRL response was not significantly affected by the infu
sion of an opiate antagonist. On the contrary, a significant inhibitio
n of the TSH response was observed in the group of TRH-responder patie
nts (delta TSH after TRH 4.76 +/- 1.11 mu U/ml, after NAL +/- TRH 2.81
+/- 0.99 mu U/ml, p < 0.05). No significant effects were observed in
the TRH nonresponder patients (delta TSH after TRH 4.58 +/- 1.44 mu U/
ml, after NAL +/- TRH 6.26 +/- 3.27 mu U/ml). The differences observed
in the two groups of patients could be ascribed to a different endoge
nous somatostatinergic tone and could fournish a prognostic indication
in acromegalic patients.